Best-value biological medicines: Tocilizumab
The Medicines Management Programme has identified a best-value biological (BVB) medicine for medicinal products containing tocilizumab on the High Tech Arrangement.
The MMP recommends the following as a BVB medicine for tocilizumab on the High Tech Arrangement:
- Tyenne® (Fresenius Kabi Ireland)
A copy of the MMP Evaluation Report is available in the Related Files section below.